US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 24, 2020 (7 years ago)

Ertapenem in 100ML 0.9% NACL 1GM Injectable

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack Of Processing Controls

What was recalled

Ertapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Recalling firm
Redline Pharmacy Solutions
Origin
NE, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1009-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ertapenem recalls

See all
Class II · Moderate risk Terminated

Ertapenem

Reason Lack of sterility assurance

Sentara Infusion Services D-0291-2023
Class II · Moderate risk Terminated

Invanz

Reason Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Sentara Enterprises D-0628-2016
Class II · Moderate risk Ongoing

Invanz

Reason Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

Franck's Lab Inc dba Trinity Care Solutions D-1460-2014